Despite meeting with executives looking to avert potential litigation, the Department of Justice is planning to intervene in UnitedHealth Group's acquisition of home health company Amedisys.

BATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported third-quarter earnings of $16.9 million. The Baton Rouge, Louisiana-based company said it had net ...

UnitedHealth's (NYSE:UNH) planned $3.3 billion acquisition of Amedisys (NASDAQ:AMED) is likely to close despite reports that ...

Amedisys (NASDAQ:AMED) dropped 5.1% amid a report that a potential divestiture buyer in its planned sale to UnitedHealth ...

We got onto the buzz about “transparent aluminum” as a result of a Tweet from whence the image above came. This Tweet was posted by [Jo Pitesky], a Science Systems Engineer at the Jet ...

Amedisys (AMED) came out with quarterly earnings of $1 per share, missing the Zacks Consensus Estimate of $1.14 per share. This compares to earnings of $0.98 per share a year ago. These figures ...

BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024. Three-Month ...

AMED Or CHE: Which Is The Better Value Stock Right Now? Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Amedisys (NASDAQ: AMED) and Chemed (NYSE: CHE).

Amedisys shares have risen roughly 3% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $97.71, a rise of nearly 6% in the last 12 months.